45 results on '"Villa-Abrille, María C."'
Search Results
2. Reactive oxygen species partially mediate high dose angiotensin II-induced positive inotropic effect in cat ventricular myocytes
- Author
-
Yeves, Alejandra M., Caldiz, Claudia I., Aiello, Ernesto A., Villa-Abrille, María C., and Ennis, Irene L.
- Published
- 2015
- Full Text
- View/download PDF
3. Physiological cardiac hypertrophy: Critical role of AKT in the prevention of NHE-1 hyperactivity
- Author
-
Yeves, Alejandra M., Villa-Abrille, María C., Pérez, Néstor G., Medina, Andrés J., Escudero, Eduardo M., and Ennis, Irene L.
- Published
- 2014
- Full Text
- View/download PDF
4. Early Activation of Intracellular Signals after Myocardial Stretch: Anrep Effect, Myocardial Hypertrophy and Heart Failure
- Author
-
Cingolani, Horacio E., Villa-Abrille, María C., Caldiz, Claudia I., Ennis, Irene L., Cingolani, Oscar H., Morgan, Patricio E., Aiello, Ernesto A., Pérez, Néstor Gustavo, Kamkin, Andre, editor, and Lozinsky, Ilya, editor
- Published
- 2012
- Full Text
- View/download PDF
5. Early Hypertrophic Signals After Myocardial Stretch. Role of Reactive Oxygen Species and the Sodium/Hydrogen Exchanger
- Author
-
Cingolani, Horacio E., Pérez, Néstor G., Caldiz, Claudia I., Garciarena, Carolina D., De Giusti, Verónica C., Correa, María V., Villa-Abrille, María C., Yeves, Alejandra M., Ennis, Irene L., de Cingolani, Gladys Chiappe, Aiello, Ernesto A., Kamkin, Andre, editor, and Kiseleva, Irina, editor
- Published
- 2010
- Full Text
- View/download PDF
6. Antibodies against the cardiac sodium/bicarbonate co-transporter (NBCe1) as pharmacological tools
- Author
-
De Giusti, Verónica C, Orlowski, Alejandro, Villa-Abrille, María C, de Cingolani, Gladys E Chiappe, Casey, Joseph R, Alvarez, Bernardo V, and Aiello, Ernesto A
- Published
- 2011
- Full Text
- View/download PDF
7. The Anrep effect requires transactivation of the epidermal growth factor receptor
- Author
-
Villa-Abrille, María C., Caldiz, Claudia I., Ennis, Irene L., Nolly, Mariela B., Casarini, María J., Chiappe de Cingolani, Gladys E., Cingolani, Horacio E., and Pérez, Néstor G.
- Published
- 2010
- Full Text
- View/download PDF
8. The electrogenic Na+/HCO3− cotransport modulates resting membrane potential and action potential duration in cat ventricular myocytes
- Author
-
Villa-Abrille, María C., Petroff, Martín G. Vila, and Aiello, Ernesto A.
- Published
- 2007
9. From Anrepʼs Phenomenon to Myocardial Hypertrophy: Role of the Na+/H+ Exchanger
- Author
-
Ennis, Irene L., Cingolani, Horacio E., Garciarena, Carolina D., Camilión de Hurtado, María C., Villa-Abrille, María C., Aiello, Ernesto A., and Pérez, Néstor G.
- Published
- 2007
10. Interaction of Pacemaker Cells and Fibroblasts in the SAN. Another Way of Setting the "Clocks"?
- Author
-
De Giusti, Verónica C., Villa-Abrille, María C., and Aiello, Ernesto A.
- Published
- 2022
- Full Text
- View/download PDF
11. p38-MAP Kinase Negatively Regulates the Slow Force Response to Stretch in Rat Myocardium through the Up-Regulation of Dual Specificity Phosphatase 6 (DUSP6).
- Author
-
Zavala, Maite R., Díaz, Romina G., Medina, Andrés J., Acosta, María P., Escudero, Daiana S., Ennis, Irene L., Pérez, Néstor G., and Villa-Abrille, María C.
- Subjects
MYOCARDIUM ,PHOSPHATASES ,PHOSPHORYLATION ,WESTERN immunoblotting ,IMMUNOPRECIPITATION - Abstract
Background/Aims: Myocardial stretch increases cardiac force in two consecutive phases: The first one due to Frank-Starling mechanism, followed by the gradually developed slow force response (SFR). The latter is the mechanical counterpart of an autocrine/paracrine mechanism involving the release of angiotensin II (Ang II) and endothelin (ET) leading to Na
+ /H+ exchanger 1 (NHE-1) phosphorylation and activation. Since previous evidence indicates that p38-MAP kinase (p38-MAPK) negatively regulates the Ang II-induced NHE-1 activation in vascular smooth muscle and the positive inotropic effect of ET in the heart, we hypothesized that this kinase might modulate the magnitude of the SFR to stretch. Methods: Experiments were performed in isolated rat papillary muscles subjected to sudden stretch from 92 to 98% of its maximal length, in the absence or presence of the p38-MAPK inhibitor SB202190, or its inactive analogous SB202474. Western blot technique was used to determine phosphorylation level of p38-MAPK, ERK1/2, p90RSK and NHE-1 (previously immunoprecipitated with NHE-1 polyclonal antibody). Dual specificity phosphatase 6 (DUSP6) expression was evaluated by RT-PCR and western blot. Additionally, the Na+ -dependent intracellular pH recovery from an ammonium prepulse-induced acid load was used to asses NHE-1 activity. Results: The SFR was larger under p38-MAPK inhibition (SB202190), effect that was not observed in the presence of an inactive analogous (SB202474). Myocardial stretch activated p38-MAPK, while pre-treatment with SB202190 precluded this effect. Inhibition of p38-MAPK increased stretched-induced NHE-1 phosphorylation and activity, key event in the SFR development. Consistently, p38-MAPK inhibition promoted a greater increase in ERK1/2-p90RSK phosphorylation/activation after myocardial stretch, effect that may certainly be responsible for the observed increase in NHE-1 phosphorylation under this condition. Myocardial stretch induced up-regulation of the DUSP6, which specifically dephosphorylates ERK1/2, effect that was blunted by SB202190. Conclusion: Taken together, our data support the notion that p38-MAPK activation after myocardial stretch restricts the SFR by limiting ERK1/2-p90RSK phosphorylation, and consequently NHE-1 phosphorylation/activity, through a mechanism that involves DUSP6 up-regulation. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
12. Aldosterone stimulates the cardiac Na(+)/H(+) exchanger via transactivation of the epidermal growth factor receptor.
- Author
-
De Giusti, Verónica C., Nolly, Mariela B., Yeves, Alejandra M., Caldiz, Claudia I., Villa-Abrille, María C., de Cingolani, Gladys E. Chiappe, Ennis, Irene L., Cingolani, Horacio E., Aiello, Ernesto A., De Giusti, Verónica C, Villa-Abrille, María C, and Chiappe de Cingolani, Gladys E
- Abstract
The use of antagonists of the mineralocorticoid receptor in the treatment of myocardial hypertrophy and heart failure has gained increasing importance in the last years. The cardiac Na(+)/H(+) exchanger (NHE-1) upregulation induced by aldosterone could account for the genesis of these pathologies. We tested whether aldosterone-induced NHE-1 stimulation involves the transactivation of the epidermal growth factor receptor (EGFR). Rat ventricular myocytes were used to measure intracellular pH with epifluorescence. Aldosterone enhanced the NHE-1 activity. This effect was canceled by spironolactone or eplerenone (mineralocorticoid receptor antagonists), but not by mifepristone (glucocorticoid receptor antagonist) or cycloheximide (protein synthesis inhibitor), indicating that the mechanism is mediated by the mineralocorticoid receptor triggering nongenomic pathways. Aldosterone-induced NHE-1 stimulation was abolished by the EGFR kinase inhibitor AG1478, suggesting that is mediated by transactivation of EGFR. The increase in the phosphorylation level of the kinase p90(RSK) and NHE-1 serine703 induced by aldosterone was also blocked by AG1478. Exogenous epidermal growth factor mimicked the effects of aldosterone on NHE-1 activity. Epidermal growth factor was also able to increase reactive oxygen species production, and the epidermal growth factor-induced activation of the NHE-1 was abrogated by the reactive oxygen species scavenger N-2-mercaptopropionyl glycine, indicating that reactive oxygen species are participating as signaling molecules in this mechanism. Aldosterone enhances the NHE-1 activity via transactivation of the EGFR, formation of reactive oxygen species, and phosphorylation of the exchanger. These results call attention to the consideration of the EGFR as a new potential therapeutic target of the cardiovascular pathologies involving the participation of aldosterone. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
13. Myocardial Mineralocorticoid Receptor Activation by Stretching and Its Functional Consequences.
- Author
-
Díaz, Romina G., Pérez, Néstor G., Morgan, Patricio E., Villa-Abrille, María C., Caldiz, Claudia I., Nolly, Mariela B., Portiansky, Enrique L., Ennis, Irene L., and Cingolani, Horacio E.
- Abstract
Myocardial stretch triggers an angiotensin II-dependent autocrine/paracrine loop of intracellular signals, leading to reactive oxygen species-mediated activation of redox-sensitive kinases. Based on pharmacological strategies, we previously proposed that mineralocorticoid receptor (MR) is necessary for this stretch-triggered mechanism. Now, we aimed to test the role of MR after stretch by using a molecular approach to avoid secondary effects of pharmacological MR blockers. Small hairpin interference RNA capable of specifically knocking down the MR was incorporated into a lentiviral vector (1-shMR) and injected into the left ventricular wall of Wistar rats. The same vector but expressing a nonsilencing sequence (scramble) was used as control. Lentivirus propagation through the left ventricle was evidenced by confocal microscopy. Myocardial MR expression, stretch-triggered activation of redox-sensitive kinases (ERK1/2-p90
RSK ), the consequent Na+ /H+ exchanger-mediated changes in pHi (HEPES-buffer), and its mechanical counterpart, the slow force response, were evaluated. Furthermore, reactive oxygen species production in response to a low concentration of angiotensin II (1.0 nmol/L) or an equipotent concentration of epidermal growth factor (0.1 µg/mL) was compared in myocardial tissue slices from both groups. Compared with scramble, animals transduced with 1-shMR showed (1) reduced cardiac MR expression, (2) cancellation of angiotensin II-induced reactive oxygen species production but preservation of epidermal growth factor-induced reactive oxygen species production, (3) cancellation of stretch-triggered increase in ERK1/2-p90RSK phosphorylation, (4) lack of stretch-induced Na+ /H+ exchanger activation, and (5) abolishment of the slow force response. Our results provide strong evidence that MR activation occurs after myocardial stretch and is a key factor to promote redox-sensitive kinase activation and their downstream consequences. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
14. Mitochondrial NHE1: a newly identified target to prevent heart disease.
- Author
-
Alvarez, Bernardo V. and Villa-Abrille, María C.
- Subjects
MITOCHONDRIA ,ORGANELLES ,HEART diseases ,CARDIOVASCULAR diseases ,ISCHEMIA - Abstract
Mitochondrial damage has been associated with early steps of cardiac dysfunction in heart subjected to ischemic stress, oxidative stress and hypertrophy. A common feature for the mitochondrial deterioration is the loss of the mitochondrial membrane potential (▵Ψ m) with the concomitant irreversible opening of the mitochondrial permeability transition pore (MPTP) which follows the mitochondrial Ca
2+ overload, and the subsequent mitochondrial swelling. We have recently characterized the expression of the Na2+ /H2+ exchanger 1 (mNHE1) in mitochondrial membranes. This surprising observation provided a unique target for the prevention of the Ca2+ -induced MPTP opening, based on the inhibition of the NHE1m. In this line, inhibition of NHE1m activity and/or reduction of NHE1m expression decreased the Ca2+ -induced mitochondrial swelling and the release of reactive oxygen species (ROS) in isolated cardiac mitochondria and preserved the ▵Ψ m in isolated cardiomyocytes. Mitochondrial NHE1 thus represents a novel target to prevent cardiac disease, opening new avenues for future research. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
15. Silencing of cardiac mitochondrial NHE1 prevents mitochondrial permeability transition pore opening.
- Author
-
Villa-Abrille, María C., Cingolani, Eugenio, Cingolani, Horacio E., and Alvarez, Bernardo V.
- Subjects
- *
MITOCHONDRIAL membranes , *ISCHEMIA , *REPERFUSION injury , *ELECTRON microscopy , *LABORATORY rats , *CYTOCHROME c - Abstract
Inhibition of Na+/H+ exchanger 1 (NHE1) reduces cardiac ischemia-reperfusion (I/R) injury and also cardiac hypertrophy and failure. Although the mechanisms underlying these NHE1-mediated effects suggest delay of mitochondrial permeability transition pore (MPTP) opening, and reduction of mitochondrial-derived superoxide production, the possibility of NHE1 blockade targeting mitochondria has been incompletely explored. A short-hairpin RNA sequence mediating specific knock down of NHE1 expression was incorporated into a lentiviral vector (shRNA-NHE1) and transduced in the rat myocardium. NHE1 expression of mitochondrial lysates revealed that shRNA-NHE1 transductions reduced mitochondrial NHE1 (mNHE1) by ~60%, supporting the expression of NHE1 in mitochondria membranes. Electron microscopy studies corroborate the presence of NHE1 in heart mitochondria. Immunostaining of rat cardiomyocytes also suggests colocalization of NHE1 with the mitochondrial marker cytochrome c oxidase. To examine the functional role of mNHE1, mitochondrial suspensions were exposed to increasing concentrations of CaCl2 to induce MPTP opening and consequently mitochondrial swelling. shRNA-NHE1 transduction reduced CaCl2-induced mitochondrial swelling by 64 ± 4%. Whereas the NHE1 inhibitor HOE-642 (10 μM) decreased mitochondrial Ca2+-induced swelling in rats transduced with nonsilencing RNAi (37 ± 6%), no additional HOE-642 effects were detected in mitochondria from rats transduced with shRNA-NHE1. We have characterized the expression and function of NHE1 in rat heart mitochondria. Because mitochondria from rats injected with shRNA-NHE1 present a high threshold for MPTP formation, the beneficial effects of NHE1 inhibition in I/R resulting from mitochondrial targeting should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
16. The electrogenic Na+/HCO3− cotransport modulates resting membrane potential and action potential duration in cat ventricular myocytes.
- Author
-
Villa-Abrille, María C., Petroff, Martín G. Vila, and Aiello, Ernesto A.
- Abstract
Perforated whole-cell configuration of patch clamp was used to determine the contribution of the electrogenic Na+/HCO3− cotransport (NBC) on the shape of the action potential in cat ventricular myocytes. Switching from Hepes to HCO3− buffer at constant extracellular pH (pHo) hyperpolarized resting membrane potential (RMP) by 2.67 ± 0.42 mV ( n= 9, P < 0.05). The duration of action potential measured at 50% of repolarization time (APD50) was 35.8 ± 6.8% shorter in the presence of HCO3− than in its absence ( n= 9, P < 0.05). The anion blocker SITS prevented and reversed the HCO3−-induced hyperpolarization and shortening of APD. In addition, no HCO3−-induced hyperpolarization and APD shortening was observed in the absence of extracellular Na+. Quasi-steady-state currents were evoked by 8 s duration voltage-clamped ramps ranging from −130 to +30 mV. A novel component of SITS-sensitive current was observed in the presence of HCO3−. The HCO3−-sensitive current reversed at −87 ± 5 mV ( n= 7), a value close to the expected reversal potential of an electrogenic Na+/HCO3− cotransport with a HCO3−:Na+ stoichiometry ratio of 2: 1. The above results allow us to conclude that the cardiac electrogenic Na+/HCO3− cotransport has a relevant influence on RMP and APD of cat ventricular cells. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
17. The positive inotropic effect of angiotensin II: role of endothelin-1 and reactive oxygen species.
- Author
-
Cingolani, Horacio E., Villa-Abrille, María C., Cornelli, Mariana, Nolly, Alejandro, Ennis, Irene L., Garciarena, Carolina, Suburo, Angela M., Torbidoni, Vanesa, Correa, María V., Hurtado, María C. Camilión de, Aiello, Ernesto A., and Camiliónde Hurtado, María C
- Published
- 2006
- Full Text
- View/download PDF
18. Myocardial hypertrophy of normotensive WistarKyoto rats.
- Author
-
Aiello, Ernesto A., Villa-Abrille, María C., Escudero, Eduardo M., Portiansky, Enrique L., Pérex, Néstor G., Camilíon de Hurtado, María C., and Cingolani, Horacio E.
- Subjects
- *
CARDIAC hypertrophy , *MUSCLE cells , *BLOOD pressure , *HEART fibrosis , *RATS - Abstract
In our studies with spontaneously hypertensive (SHR), Wistar-Kyoto (WKY), and Wistar rats, we observed normotensive WKY rats with cardiac hypertrophy determined by a greater left ventricular (LV) mass (LVM)-to-body weight (BW) ratio (LVM/BW) than that of normotensive Wistar rats. Thus we compared the following parameters in SHR, WKY, and Wistar rats: LVM/BW, cell capacitance as index of total surface area of the myocytes, length, width, and cross-sectional area of cardiac myocytes, LV collagen volume fraction, and myocardial stiffness. The LVM/BW of WKY (2.41 ± 0.03 mg/g, n = 41) was intermediate between SHR (2.82 ± 0.04 mg/g, n = 47) and Wistar rats (1.98 ± 0.04 mg/g, n = 28). A positive correlation between blood pressure and LVM was found in SHR, whereas no such relationship was observed in WKY or Wistar rats. Cell capacitance and cross-sectional area were not significantly different in SHR and WKY rats; these values were significantly higher than those of Wistar rats. The cell length was smaller but the width was similar in WKY compared with SHR. Papillary muscles isolated from the LV of WKY and SHR were stiffer than those from Wistar rats. Consistently, a greater level of myocardial fibrosis was detected in WKY and SHR compared with Wistar rats. These findings demonstrate blood pressure-independent cardiac hypertrophy in normotensive WKY rats. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
19. A low dose of angiotensin II increases inotropism through activation of reverse Na+/Ca2+ exchange by endothelin release
- Author
-
Pérez, Néstor G., Villa-Abrille, María C., Aiello, Ernesto A., Dulce, Raúl A., Cingolani, Horacio E., and Camilión de Hurtado, María C.
- Subjects
- *
ENDOTHELINS , *AUTOCRINE mechanisms , *ANGIOTENSIN II , *CARDIAC contraction - Abstract
Objective: This work was aimed to prove that release/formation of endogenous endothelin acting in an autocrine/paracrine fashion contributes to the increase in contractility promoted by a low dose of angiotensin II. Methods: Isolated cat papillary muscles were used for force, pHi, [Na+]i and [Ca2+]i measurements and isolated cat myocytes for patch-clamp experiments. Results: In papillary muscles, 1.0 nmol/l angiotensin II increased force by 23±2% (n=4, P<0.05), [Na+]i by 2.2±0.2 mmol/l (n=4, P<0.05), and peak (but not diastolic) Ca2+ from 0.674±0.11 to 0.768±0.13 μmol/l (n=4, P<0.05), without affecting pHi. Force and [Na+]i increase were abolished by inhibition of the Na+/H+ exchanger (NHE) with the inhibitor HOE642, blockade of endothelin receptors with the nonselective antagonist TAK044 and by inhibition of the endothelin-converting enzyme with phosphoramidon. Force but not [Na+]i increase was abolished by inhibition of reverse Na+/Ca2+ exchange (NCX) with the inhibitor KB-R7943. Similar increase in force (21±2%, n=4, P<0.05) and in [Na+]i (2.4±0.4 mmol/l, n=4, P<0.05) that were also suppressed by TAK044 and HOE642 were induced by exogenous 5.0 nmol/l endothelin-1. KB-R7943 reverted the endothelin-1 effect on force but not on [Na+]i. In isolated myocytes, exogenous endothelin-1 dose-dependently increased the NCX current and shifted the NCX reversal potential (ENCX) to a more negative value (ΔENCX: −10±3 and −17±5 mV, with 1 and 10 nmol/l endothelin-1, respectively, n=12). The latter effect was prevented by HOE642. Conclusion: Taken together, the results indicate that a low dose of angiotensin II induces release of endothelin, which, in autocrine/paracrine fashion activates the Na+/H+ exchanger, increases [Na+]i and changes ENCX, promoting the influx of Ca2+ that leads to a positive inotropic effect (PIE). [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
20. Autocrine Stimulation of Cardiac Na+-Ca2+ Exchanger Currents by Endogenous Endothelin Released by Angiotensin II.
- Author
-
Aiello, Ernesto A., Villa-Abrille, María C., and Cingolani, Horacio E.
- Published
- 2002
21. Silencing of epidermal growth factor receptor reduces Na+/H+ exchanger 1 activity and hypertensive cardiac hypertrophy.
- Author
-
Brea, María S., Díaz, Romina G., Escudero, Daiana S., Zavala, Maite R., Portiansky, Enrique L., Villa-Abrille, María C., Caldiz, Claudia I., Pérez, Néstor G., and Morgan, Patricio E.
- Subjects
- *
CARDIAC hypertrophy , *HEART ventricles , *PROTEIN expression , *PAPILLARY muscles , *POST-translational modification - Abstract
Pathological cardiac hypertrophy (PCH) can be triggered by epidermal growth factor receptor (EGFR) transactivation. Progression of PCH can be prevented by inhibition of hyperactive Na+/H+ exchanger isoform 1 (NHE1). We first aimed, to limit PCH of spontaneously hypertensive rats (SHR) by specific and localized silencing of cardiac EGFR, and second to study the connection of its activation pathway with cardiac NHE1 activity. Short hairpin RNA (shRNA) against EGFR was delivered with a lentivirus (l-shEGFR) in the cardiac left ventricle (LV) wall. Protein expression was analyzed by immunoblots, and NHE1 activity was indirectly measured in isolated papillary muscles by rate of pH i recovery from transient acidification. EGFR protein expression in the LV was reduced compared to the group injected with l-shSCR (Scrambled sequence) without changes in ErbB2 or ErbB4. Hypertrophic parameters together with cardiomyocytes cross sectional area were reduced in animals injected with l-shEGFR. Echocardiographic analysis exhibited a reduced fractional shortening in the l-shSCR group 30 days following treatment that was not observed in l-shEGFR group. l-shEGFR treated rats presented a reduced basal production of reactive oxygen species and decreased lipid peroxidation. NHE1 activity was significantly diminished in hearts with a partial EGFR silencing, without modification of its protein expression. We conclude that specifically silencing cardiac EGFR expression prevents progression of PCH through a pathway that involves a decrease in the NHE1 activity. Lentiviral vectors prove to be a valuable tool for long term expression of shRNA, bringing the possibility to extend its use in clinical area. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
22. Thioredoxin 1 (TRX1) Overexpression Cancels the Slow Force Response (SFR) Development.
- Author
-
Zavala MR, Díaz RG, Villa-Abrille MC, and Pérez NG
- Abstract
The stretch of cardiac muscle increases developed force in two phases. The first phase occurs immediately after stretch and is the expression of the Frank-Starling mechanism, while the second one or slow force response (SFR) occurs gradually and is due to an increase in the calcium transient amplitude. An important step in the chain of events leading to the SFR generation is the increased production of reactive oxygen species (ROS) leading to redox sensitive ERK1/2, p90RSK, and NHE1 phosphorylation/activation. Conversely, suppression of ROS production blunts the SFR. The purpose of this study was to explore whether overexpression of the ubiquitously expressed antioxidant molecule thioredoxin-1 (TRX1) affects the SFR development and NHE1 phosphorylation. We did not detect any change in basal phopho-ERK1/2, phopho-p90RSK, and NHE1 expression in mice with TRX1 overexpression compared to wild type (WT). Isolated papillary muscles from WT or TRX1-overexpressing mice were stretched from 92 to 98% of its maximal length. A prominent SFR was observed in WT mice that was completely canceled in TRX1 animals. Interestingly, myocardial stretch induced a significant increase in NHE1 phosphorylation in WT mice that was not detected in TRX1-overexpressing mice. These novel results suggest that magnification of cardiac antioxidant defense power by overexpression of TRX1 precludes NHE1 phosphorylation/activation after stretch, consequently blunting the SFR development., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Zavala, Díaz, Villa-Abrille and Pérez.)
- Published
- 2021
- Full Text
- View/download PDF
23. Silencing of NHE-1 blunts the slow force response to myocardial stretch.
- Author
-
Pérez NG, Nolly MB, Roldan MC, Villa-Abrille MC, Cingolani E, Portiansky EL, Alvarez BV, Ennis IL, and Cingolani HE
- Subjects
- Acidosis metabolism, Acidosis physiopathology, Animals, Down-Regulation, Hydrogen-Ion Concentration, Injections, Intramuscular, Male, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, Papillary Muscles physiopathology, Phosphorylation, RNA, Small Interfering administration & dosage, Rats, Rats, Wistar, Signal Transduction, Sodium-Hydrogen Exchanger 1, Sodium-Hydrogen Exchangers genetics, Time Factors, Mechanoreceptors metabolism, Muscle Strength, Myocardial Contraction, Papillary Muscles metabolism, RNA Interference, Sodium-Hydrogen Exchangers metabolism
- Abstract
Myocardial stretch induces a biphasic force response: a first abrupt increase followed by a slow force response (SFR), believed to be the in vitro manifestation of the Anrep effect. The SFR is due to an increase in Ca²⁺ transient of unclear mechanism. We proposed that Na⁺/H⁺ exchanger (NHE-1) activation is a key factor in determining the contractile response, but recent reports challenged our findings. We aimed to specifically test the role of the NHE-1 in the SFR. To this purpose small hairpin interference RNA capable of mediating specific NHE-1 knockdown was incorporated into a lentiviral vector (l-shNHE1) and injected into the left ventricular wall of Wistar rats. Injection of a lentiviral vector expressing a nonsilencing sequence (scramble) served as control. Myocardial NHE-1 protein expression and function (the latter evaluated by the recovery of pH(i) after an acidic load and the SFR) were evaluated. Animals transduced with l-shNHE1 showed reduced NHE-1 expression (45 ± 8% of controls; P < 0.05), and the presence of the lentivirus in the left ventricular myocardium, far from the site of injection, was evidenced by confocal microscopy. These findings correlated with depressed basal pH(i) recovery after acidosis [(max)dpH(i)/dt 0.055 ± 0.008 (scramble) vs. 0.009 ± 0.004 (l-shNHE1) pH units/min, P < 0.05], leftward shift of the relationship between J(H⁺) (H⁺ efflux corrected by the intrinsic buffer capacity), and abolishment of SFR (124 ± 2 vs. 101 ± 2% of rapid phase; P < 0.05) despite preserved ERK1/2 phosphorylation [247 ± 12 (stretch) and 263 ± 23 (stretch l-shNHE1) % of control; P < 0.05 vs. nonstretched control], well-known NHE-1 activators. Our results provide strong evidence to propose NHE-1 activation as key factor in determining the SFR to stretch.
- Published
- 2011
- Full Text
- View/download PDF
24. [Angiotensin II-induced endothelin-1 release in cardiac myocytes].
- Author
-
Villa-Abrille MC, Cingolani HE, Garciarena CD, Ennis IL, and Aiello EA
- Subjects
- Analysis of Variance, Animals, Cats, Myocytes, Cardiac metabolism, Papillary Muscles metabolism, Receptor, Angiotensin, Type 1 metabolism, Reverse Transcriptase Polymerase Chain Reaction, Sodium-Calcium Exchanger metabolism, Angiotensin II pharmacology, Endothelin-1 metabolism, Myocardial Contraction drug effects, Myocytes, Cardiac drug effects, Reactive Oxygen Species metabolism, Vasoconstrictor Agents pharmacology
- Abstract
Many of the effects thought to be due to angiotensin II (Ang II) are due to the release/formation of endothelin (ET). We tested whether Ang II elicits its positive inotropic effect (PIE) by the action of endogenous ET-1 and the role played by the reactive oxygen species (ROS) in this mechanism. Experiments were performed in cat isolated ventricular myocytes in which sarcomere shortening (SS) was measured to asses contractility after pharmacological interventions and the effect of Ang II on inotropism were analyzed. Ang II 1 nM increased SS by 31.8 +/- 3.8% (p < 0.05). This PIE was cancelled by AT1 receptor blockade, by ET-1 receptors blockade, by Na+/H+ exchanger (NHE) inhibition, by reverse mode Na+/Ca2+ exchanger (NCX) blockade or by ROS scavenging. Ang II 100 nM increases SS by 70.5 +/- 7.6% (p < 0.05). This PIE was completely abolished by AT1 receptors blockade and were partially bocked by ET-1 receptors blockade, by NHE inhibition, by reverse mode NCX blockade or by ROS scavenging. Ang II increased preproET-1 mRNA, effect that was blunted by AT1 receptors blockade. We conclude that Ang II induces (through its AT1 receptor) release/formation of ET-1, which acting in autocrine fashion on ET receptors of the isolated myocytes increases inotropism through NHE stimulation and NCX reverse mode activation. The participation of ROS is involved is this chain of events.
- Published
- 2006
25. A low dose of angiotensin II increases inotropism through activation of reverse Na(+)/Ca(2+) exchange by endothelin release.
- Author
-
Pérez NG, Villa-Abrille MC, Aiello EA, Dulce RA, Cingolani HE, and Camilión de Hurtado MC
- Subjects
- Angiotensin II Type 1 Receptor Blockers, Animals, Cats, Electrophysiology, Endothelin Receptor Antagonists, Enzyme Inhibitors pharmacology, Glycopeptides pharmacology, Guanidines pharmacology, In Vitro Techniques, Losartan pharmacology, Muscle Contraction drug effects, Papillary Muscles metabolism, Patch-Clamp Techniques, Peptides, Cyclic pharmacology, Sulfones pharmacology, Thiourea pharmacology, Angiotensin II pharmacology, Endothelin-1 pharmacology, Papillary Muscles drug effects, Sodium-Calcium Exchanger metabolism, Thiourea analogs & derivatives
- Abstract
Objective: This work was aimed to prove that release/formation of endogenous endothelin acting in an autocrine/paracrine fashion contributes to the increase in contractility promoted by a low dose of angiotensin II., Methods: Isolated cat papillary muscles were used for force, pH(i), [Na(+)](i) and [Ca(2+)](i) measurements and isolated cat myocytes for patch-clamp experiments., Results: In papillary muscles, 1.0 nmol/l angiotensin II increased force by 23+/-2% (n=4, P<0.05), [Na(+)](i) by 2.2+/-0.2 mmol/l (n=4, P<0.05), and peak (but not diastolic) Ca(2+) from 0.674+/-0.11 to 0.768+/-0.13 micromol/l (n=4, P<0.05), without affecting pH(i). Force and [Na(+)](i) increase were abolished by inhibition of the Na(+)/H(+) exchanger (NHE) with the inhibitor HOE642, blockade of endothelin receptors with the nonselective antagonist TAK044 and by inhibition of the endothelin-converting enzyme with phosphoramidon. Force but not [Na(+)](i) increase was abolished by inhibition of reverse Na(+)/Ca(2+) exchange (NCX) with the inhibitor KB-R7943. Similar increase in force (21+/-2%, n=4, P<0.05) and in [Na(+)](i) (2.4+/-0.4 mmol/l, n=4, P<0.05) that were also suppressed by TAK044 and HOE642 were induced by exogenous 5.0 nmol/l endothelin-1. KB-R7943 reverted the endothelin-1 effect on force but not on [Na(+)](i). In isolated myocytes, exogenous endothelin-1 dose-dependently increased the NCX current and shifted the NCX reversal potential (E(NCX)) to a more negative value (DeltaE(NCX): -10+/-3 and -17+/-5 mV, with 1 and 10 nmol/l endothelin-1, respectively, n=12). The latter effect was prevented by HOE642., Conclusion: Taken together, the results indicate that a low dose of angiotensin II induces release of endothelin, which, in autocrine/paracrine fashion activates the Na(+)/H(+) exchanger, increases [Na(+)](i) and changes E(NCX), promoting the influx of Ca(2+) that leads to a positive inotropic effect (PIE).
- Published
- 2003
- Full Text
- View/download PDF
26. Autocrine stimulation of cardiac Na(+)-Ca(2+) exchanger currents by endogenous endothelin released by angiotensin II.
- Author
-
Aiello EA, Villa-Abrille MC, and Cingolani HE
- Subjects
- Angiotensin II pharmacology, Animals, Autocrine Communication drug effects, Cats, Endothelin Receptor Antagonists, In Vitro Techniques, Ion Transport drug effects, Ion Transport physiology, Membrane Potentials drug effects, Myocardium cytology, Patch-Clamp Techniques, Peptides, Cyclic pharmacology, Sodium-Calcium Exchanger antagonists & inhibitors, Thiourea pharmacology, Angiotensin II metabolism, Autocrine Communication physiology, Endothelins metabolism, Myocardium metabolism, Sodium-Calcium Exchanger metabolism, Thiourea analogs & derivatives
- Abstract
The goal of the present study was to evaluate the effects of Ang II on the current produced by the Na(+)-Ca(2+) exchanger (I(NCX)) working in the reverse mode and the possible autocrine role played by the release of endothelin (ET) in these actions. I(NCX) was studied in isolation in cat cardiac myocytes. Angiotensin II (Ang II) (100 nmol/L) increased I(NCX) at potentials higher than 0 mV (at +60 mV: 2.07 +/- 0.22 pA/pF in control versus 2.73 +/- 0.22 pA/pF in Ang II, n=9; P<0.05). The increase in I(NCX) induced by Ang II was prevented by the treatment of the cells with the unspecific blocker of the ET receptors, TAK 044 (1 micromol/L) (at +60 mV: 2.15 +/- 0.27 pA/pF in control versus 2.01+/- 0.26 pA/pF in Ang II, n=5, NS). These results show, for the first time, that the effect of Ang II on I(NCX) is the result of the autocrine actions of ET released by the octapeptide.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.